Try our Advanced Search for more refined results
Phillips McLaughlin
-
Order | Filed: June 10, 2024 | Entered: June 10, 2024 Allergan, Inc. et al v. Revance Therapeutics, Inc. et al
Patent | Delaware
SO ORDERED
SO ORDERED, re 342 STIPULATION to Extend Time to further reduce claims and invalidity defenses to June 12, 2024. Signed by Judge Richard G. Andrews on 6/10/2024. (nms)
-
Motion | Filed: June 10, 2024 | Entered: June 10, 2024 Allergan, Inc. et al v. Revance Therapeutics, Inc. et al
Patent | Delaware
Stipulation to EXTEND Time
STIPULATION TO EXTEND TIME for the parties to file a schedule to further reduce claims and invalidity defenses to June 12, 2024 - filed by Allergan Pharmaceuticals Ireland Unlimited Company, Allergan USA, Inc., Allergan, Inc.. (Tigan, Jeremy)
-
Order | Filed: June 10, 2024 | Entered: June 10, 2024 In re: Entresto (Sacubitril/Valsartan) Patent Litigation
Patent - Abbreviated New Drug Application(ANDA) | Delaware
SO ORDERED
SO ORDERED, re (D.I. 195 in 22-cv-1395-RGA; D.I. 1379 in 20-md-2930-RGA) STIPULATION and Proposed Order to Extend Time for discovery. Signed by Judge Richard G. Andrews on 6/10/2024. Associated Cases: 1:20-md-02930-RGA, 1:22-cv-01395-RGA(nms)
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login